07:35 AM EDT, 09/23/2024 (MT Newswires) -- Ideaya Biosciences ( IDYA ) said Monday that a phase 2 trial evaluating investigational drug darovasertib for treating neoadjuvant uveal melanoma showed interim results that were clinically meaningful. About 49% of the study's patients exhibited more than 30% tumor shrinkage in diameters and showed around 61% eye preservation rate. Ideaya said it completed...

07:31 AM EDT, 09/23/2024 (MT Newswires) -- KKR (KKR) said Monday it raised $4.6 billion for its new Ascendant Fund focused on mid-cap North American companies. The fund was oversubscribed and closed at its hard cap, the company said. It received backing from investors that include public pensions, family offices, and insurance companies, KKR added. Pete Stavros and Nate Taylor,...

07:37 AM EDT, 09/09/2024 (MT Newswires) -- Centerra Gold ( CGAU ) signed a deal to acquire a 9.9% stake in Headwater Gold, equivalent to 7 million common shares, for about $1.5 million Canadian dollars ($1.1 million), Headwater said Monday. The agreement prices the investment at CA$0.22 apiece, according to Headwater. Headwater said it plans to use the proceeds for...

04:01 AM EST, 01/06/2026 (MT Newswires) -- Zeta Global ( ZETA ) said late Monday it partnered with Microsoft ( MSFT )-backed (MSFT) OpenAI, under which the latter will support Athena's next phase of development. Financial terms weren't disclosed. Athena is Zeta's superintelligent agent for enterprise marketing, the company said, adding that it also introduced a beta version to Athena,...